Cargando…
Association between Oxidative Burden and Restenosis: A Case-Control Study
BACKGROUND: In-stent restenosis (ISR) is an important clinical complication that occurs following stent implantation. The application of drug-eluting stents (DES) and even consumption of drugs such as antiplatelet agents and statins are not completely effective in reducing ISR risk. Since the number...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256427/ https://www.ncbi.nlm.nih.gov/pubmed/35799893 http://dx.doi.org/10.1155/2022/3577761 |
_version_ | 1784741111067049984 |
---|---|
author | Ganjali, Shiva Mansouri, Atena Abbasifard, Mitra Moallem, Seyed Adel Tayarani-Najaran, Zahra Sahebkar, Amirhossein |
author_facet | Ganjali, Shiva Mansouri, Atena Abbasifard, Mitra Moallem, Seyed Adel Tayarani-Najaran, Zahra Sahebkar, Amirhossein |
author_sort | Ganjali, Shiva |
collection | PubMed |
description | BACKGROUND: In-stent restenosis (ISR) is an important clinical complication that occurs following stent implantation. The application of drug-eluting stents (DES) and even consumption of drugs such as antiplatelet agents and statins are not completely effective in reducing ISR risk. Since the number of these patients continues to rise, it is pivotal to detect patients who are at a higher risk of ISR. In addition, identification of biochemical markers of ISR could give the right perspective on choosing the proper strategy to treat these patients. Several pathophysiological pathways including oxidative stress (OS) are implicated in the progression of ISR. Hence, this study aimed to evaluate the association between oxidative/anti-oxidative markers and ISR. METHODS: This was a case-control study which comprised 21 ISR, 26 NISR (non-ISR), and 20 healthy subjects. The serum levels of OS markers including malondialdehyde (MDA), thiol groups (GSH), total antioxidant capacity (TAC), and the activity of serum antioxidant enzymes such as glutathione peroxidase (GPx) and superoxide dismutase (SOD) were assessed by colorimetric methods. The overall oxidative burden was assessed using a pro-oxidant-antioxidant balance (PAB) assay. RESULTS: MDA levels were considerably higher in the ISR group when compared to healthy subjects (P = 0.004). PAB also indicated significantly higher values in both ISR (P < 0.001) and NISR (P < 0.001) groups related to healthy subjects. No significant differences were observed between the studied groups regarding thiol levels, antioxidant enzyme activities, and TAC. Multinomial logistic regression analysis showed that elevated serum levels of MDA (OR: 1.028, 95% CI: 1.008-1.048; P = 0.006) and PAB (OR: 1.076, 95% CI: 1.017-1.139; P = 0.011) were significantly associated with higher ISR risk; however, increased values of TAC (OR: 0.990, 95% CI: 0.982-0.999; P = 0.030) were significantly associated with decreased ISR risk, while after adjustment for confounders, only SOD activity (OR: 0.0, 95% CI: 0.0-0.0; P < 0.001) and PAB value (OR: 1.866, 95% CI: 1.856-1.900; P < 0.001) showed association with ISR risk. CONCLUSION: According to the present findings, some oxidative and antioxidative markers like PAB and SOD activity showed the potential in the prediction of ISR risk. |
format | Online Article Text |
id | pubmed-9256427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-92564272022-07-06 Association between Oxidative Burden and Restenosis: A Case-Control Study Ganjali, Shiva Mansouri, Atena Abbasifard, Mitra Moallem, Seyed Adel Tayarani-Najaran, Zahra Sahebkar, Amirhossein Oxid Med Cell Longev Research Article BACKGROUND: In-stent restenosis (ISR) is an important clinical complication that occurs following stent implantation. The application of drug-eluting stents (DES) and even consumption of drugs such as antiplatelet agents and statins are not completely effective in reducing ISR risk. Since the number of these patients continues to rise, it is pivotal to detect patients who are at a higher risk of ISR. In addition, identification of biochemical markers of ISR could give the right perspective on choosing the proper strategy to treat these patients. Several pathophysiological pathways including oxidative stress (OS) are implicated in the progression of ISR. Hence, this study aimed to evaluate the association between oxidative/anti-oxidative markers and ISR. METHODS: This was a case-control study which comprised 21 ISR, 26 NISR (non-ISR), and 20 healthy subjects. The serum levels of OS markers including malondialdehyde (MDA), thiol groups (GSH), total antioxidant capacity (TAC), and the activity of serum antioxidant enzymes such as glutathione peroxidase (GPx) and superoxide dismutase (SOD) were assessed by colorimetric methods. The overall oxidative burden was assessed using a pro-oxidant-antioxidant balance (PAB) assay. RESULTS: MDA levels were considerably higher in the ISR group when compared to healthy subjects (P = 0.004). PAB also indicated significantly higher values in both ISR (P < 0.001) and NISR (P < 0.001) groups related to healthy subjects. No significant differences were observed between the studied groups regarding thiol levels, antioxidant enzyme activities, and TAC. Multinomial logistic regression analysis showed that elevated serum levels of MDA (OR: 1.028, 95% CI: 1.008-1.048; P = 0.006) and PAB (OR: 1.076, 95% CI: 1.017-1.139; P = 0.011) were significantly associated with higher ISR risk; however, increased values of TAC (OR: 0.990, 95% CI: 0.982-0.999; P = 0.030) were significantly associated with decreased ISR risk, while after adjustment for confounders, only SOD activity (OR: 0.0, 95% CI: 0.0-0.0; P < 0.001) and PAB value (OR: 1.866, 95% CI: 1.856-1.900; P < 0.001) showed association with ISR risk. CONCLUSION: According to the present findings, some oxidative and antioxidative markers like PAB and SOD activity showed the potential in the prediction of ISR risk. Hindawi 2022-06-28 /pmc/articles/PMC9256427/ /pubmed/35799893 http://dx.doi.org/10.1155/2022/3577761 Text en Copyright © 2022 Shiva Ganjali et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ganjali, Shiva Mansouri, Atena Abbasifard, Mitra Moallem, Seyed Adel Tayarani-Najaran, Zahra Sahebkar, Amirhossein Association between Oxidative Burden and Restenosis: A Case-Control Study |
title | Association between Oxidative Burden and Restenosis: A Case-Control Study |
title_full | Association between Oxidative Burden and Restenosis: A Case-Control Study |
title_fullStr | Association between Oxidative Burden and Restenosis: A Case-Control Study |
title_full_unstemmed | Association between Oxidative Burden and Restenosis: A Case-Control Study |
title_short | Association between Oxidative Burden and Restenosis: A Case-Control Study |
title_sort | association between oxidative burden and restenosis: a case-control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256427/ https://www.ncbi.nlm.nih.gov/pubmed/35799893 http://dx.doi.org/10.1155/2022/3577761 |
work_keys_str_mv | AT ganjalishiva associationbetweenoxidativeburdenandrestenosisacasecontrolstudy AT mansouriatena associationbetweenoxidativeburdenandrestenosisacasecontrolstudy AT abbasifardmitra associationbetweenoxidativeburdenandrestenosisacasecontrolstudy AT moallemseyedadel associationbetweenoxidativeburdenandrestenosisacasecontrolstudy AT tayaraninajaranzahra associationbetweenoxidativeburdenandrestenosisacasecontrolstudy AT sahebkaramirhossein associationbetweenoxidativeburdenandrestenosisacasecontrolstudy |